The main target of InnoBio Fund is to provide companies developing technological and innovative products and services in the healthcare sector with equity and quasi-equity financing.
The capital invested in the fund by FSI amounts at €52m (37% of the total). In order to increase the resources of the fund, the public/private partnership founding the vehicle can be expanded to other partners in the coming months.
The fund is already managed by CDC Enterprises and a team of investors, industry experts, led by Laurent Arthaud is working. They should be able to announce its first investments by the end of the year.